Renaissance Technologies’s Celularity CELU Stock Holding History

Renaissance Technologies’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42,000	Closed	-$86.9K	–	3285
2025 Q3	$86.9K	Buy	42,000 +29,800	+244%	+$83.4K	﹤0.01%	3274
2025 Q2	$23.9K	Buy	+12,200	New	+$22.2K	﹤0.01%	3458
2025 Q1	–	Sell	-11,000	Closed	-$22.9K	–	3502
2024 Q4	$22.9K	Sell	11,000 -12,380	-53%	-$29.5K	﹤0.01%	3476
2024 Q3	$69.4K	Sell	23,380 -2,118	-8%	-$6.24K	﹤0.01%	3311
2024 Q2	$79.8K	Sell	25,498 -4,270	-14%	-$14.8K	﹤0.01%	3224
2024 Q1	$156K	Sell	29,768 -54,579	-65%	-$224K	﹤0.01%	3281
2023 Q4	$209K	Buy	84,347 +30,007	+55%	+$65.2K	﹤0.01%	3119
2023 Q3	$121K	Buy	54,340 +26,899	+98%	+$96.6K	﹤0.01%	3207
2023 Q2	$146K	Buy	27,441 +19,421	+242%	+$124K	﹤0.01%	3371
2023 Q1	$50K	Buy	8,020 +5,640	+237%	+$45.4K	﹤0.01%	3665
2022 Q4	$31K	Buy	+2,380	New	+$43.9K	﹤0.01%	3882

Other funds holding CELU

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Renaissance Technologies's CELU Position: Q4 2025 in Review

Renaissance Technologies sold out of Celularity (CELU) in Q4 2025, closing a stake of 42,000 shares — an estimated $86.9K sold.

Renaissance Technologies first reported a position in CELU in Q4 2022 and held it in 11 quarters. The position peaked at $209K in Q4 2023. 36 funds tracked by Wall St. Rank hold CELU as of Q4 2025.

Renaissance Technologies reported no remaining Celularity position as of Q4 2025 after selling out during the quarter.
Renaissance Technologies sold 42,000 Celularity shares in Q4 2025, an estimated $86.9K.
Renaissance Technologies first reported a position in Celularity in Q4 2022 and held it in 11 quarters.
Renaissance Technologies's Celularity position peaked at $209K in Q4 2023.
36 funds tracked by Wall St. Rank held Celularity as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.